Here’s a bold statement for you: the Cardinals’ top 3 prospects are so clear-cut that it’s almost unprecedented. But here’s where it gets controversial—while JJ Wetherholt and Liam Doyle were obvious choices for the top two spots, the emergence of Raniel Rodriguez as the undisputed #3 has left many scratching their heads. It’s not that Rodriguez doesn’t deserve it; it’s just that the consensus around these three is so rare, it’s hard not to wonder what’s next. And this is the part most people miss: the drop-off after the top 3 is where the real debate begins.
Beyond Rodriguez, the Cardinals’ system becomes a fascinating puzzle. Do you favor a high-ceiling reliever with a dominant fastball, or a raw but athletic outfielder oozing with potential? Tanner Franklin, a 22-year-old RHP, is a project with a 65-grade fastball, but his path to starting is uncertain. Meanwhile, Ryan Mitchell, a 19-year-old OF, hasn’t even made his pro debut yet, but his all-around potential is tantalizing. It’s a classic case of proven tools versus untapped upside—which would you bet on?
Now, let’s dive into the newcomers. Joshua Baez might be the most intriguing prospect on this list. After striking out 35.5% of the time in 2024, he slashed that rate to 20.6% last year while boosting his power numbers. But here’s the twist: his transformation happened in his fifth pro season. Is this a late bloomer or a fluke? And what about Leonardo Bernal, whose stats took a dip in AA despite improved K/BB ratios? Was he just unlucky, or is there more to the story?
Brandon Clarke’s stats are a head-scratcher. A 47.2% strikeout rate and 5.6% walk rate in Low A should translate to a lower DRA than 3.66, right? Yet, his High A numbers align perfectly. Is he a future MLB reliever, or will command issues hold him back? And what about Tink Hence, who’s healthy but hasn’t pitched like it? If 2026 isn’t his breakout year, could a move to the bullpen be in his future?
Deniel Ortiz is the wildcard. Drafted in the 16th round in 2024, he didn’t even play that year, yet he’s now a serious contender. His stats are eye-popping, but without a scouting report, it’s all about the numbers. Is he the real deal, or just a late bloomer beating up on younger competition? And Tekoah Roby, who dominated before Tommy John surgery, is now a question mark. Will he return to form, or is his stock permanently altered?
Here’s the burning question I’ll leave you with: In a system loaded with potential, which prospect are you willing to bet on despite the risks? The proven but flawed, the raw but athletic, or the late bloomer with something to prove? Cast your vote, and let’s spark some debate in the comments. Who’s your #4, and why?
